CBC, CBG, and CBN—oh, my!

You’ve already heard about CBD, but how familiar are you with the lesser-known cannabinoids in the hemp family? If you’re encountering these terms for the first time, the many varieties of “CB-” cannabinoids might seem initially unapproachable, but rest assured: these naturally occurring chemical compounds are far less threatening than actual lions, tigers, and bears. In fact, cannabinoids offer a wide array of applications, and understanding how these popular cannabinoids affect the mind and body allows you to select cannabinoid products that support your specific needs. So why not take... Read More


Introducing CBD To Your Pets

We all love our pets: it doesn’t matter how many times they shred your pillows or steal your food when you’re not looking, the love is still there. Our animals are part of our families and, just like our human family members, we want what’s best for them. Recently, CBD for pets has emerged as a new contender in the realm of pet wellness. Just like us, animals experience similar effects from using CBD. This is because all mammals have an endocannabinoid system (ECS). After consuming CBD, it acts as... Read More


Martha Stewart Launches New Line of CBD Products with Canopy Growth

When Martha Stewart first kindled a friendship with hip-hop icon Snoop Dogg on her show Martha in 2008, few could have predicted that the pair would go on to become co-stars in the 2016 series Martha & Snoop’s Potluck Dinner Party, and now, fellow Canopy Growth partners. After Snoop successfully partnered with Tweed, a subsidiary of Canopy Growth, in 2016, Snoop Dogg’s talent agents at Stampede Management reached out to Canopy a couple of years later to recommend the one and only Martha Stewart as the newest addition to the... Read More

Epilepsy awareness concept. Brain and encephalography in epilepsy patient during seizure attack, 3D illustration in purple color - Illustration 28/03/2019

Severe Epilepsy and CBD: An FDA-Approved Treatment That Delivers Results

In June 2018, the FDA approved prescription use of CBD oil for the treatment of seizures caused by two rare, yet severe forms of epilepsy — Dravet syndrome and Lennox-Gastaut syndrome — in patients two years of age or older. Children with these conditions can experience fifty to seventy-five seizures a day despite taking multiple prescription medications. Since younger children with these two forms of epilepsy don’t always respond well to seizure medicine, British-based company GW Pharmaceuticals took it upon itself to research and test CBD as an alternative. Epidiolex... Read More